Advanced Accelerator Applications S.A. (AAAP)
(Delayed Data from NSDQ)
$81.63 USD
+0.13 (0.16%)
Updated Feb 9, 2018 04:00 PM ET
After-Market: $81.57 -0.06 (-0.07%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$81.63 USD
+0.13 (0.16%)
Updated Feb 9, 2018 04:00 PM ET
After-Market: $81.57 -0.06 (-0.07%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Deere (DE) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Deere's (DE) Q4 results will gain from improving economic and political conditions in Brazil despite weakness in livestock sector and the lingering impact of low crop prices.
Valeant Pharmaceuticals (VRX) in Focus: Stock Moves 5.5% Higher
by Zacks Equity Research
Valeant Pharmaceuticals International (VRX) was a big mover last session, as the company saw its shares nearly 6% on the day amid huge volumes.
Novartis Buys French Radiopharmaceutical Company
by Zacks Equity Research
Novartis (NVS) plans to acquire France-based Advanced Accelerator Applications. The takeover will add RadioLigand Therapy, Lutathera, in its portfolio with potential to drive growth in the near term.
Advanced Accelerator (AAAP) in Focus: Stock Moves 10.4% Higher
by Zacks Equity Research
Advanced Accelerator (AAAP) was a big mover last session, as the company saw its shares more than 10% on the day amid huge volumes.
Advanced Accelerator (AAAP) Cancer Therapy Approved in EU
by Zacks Equity Research
Advanced Accelerator Applications' (AAAP) Lutathera gets approval in Europe as its first radionuclide therapy for the treatment of tumors in the gut.
Advanced Accelerator Applications (AAAP) in Focus: Stock Moves 7.5% Higher
by Zacks Equity Research
Advanced Accelerator Applications S.A. (AAAP) was a big mover last session, as the company saw its shares rise nearly 8% on the day.
Advanced Accelerator Gets Action Date for Lutathera from FDA
by Zacks Equity Research
The FDA granted an action date for Lutathera after the company resubmitted the New Drug Application (NDA) for the candidate.
Zacks.com featured highlights: Columbus McKinnon, The New York Times, Advanced Accelerator Applications, Enanta Pharmaceuticals and Caesars Entertainment
by Zacks Equity Research
Zacks.com featured highlights: Columbus McKinnon, The New York Times, Advanced Accelerator Applications, Enanta Pharmaceuticals and Caesars Entertainment
Buy These 5 Stocks on New Analyst Coverage
by Zacks Equity Research
Increased analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.
Advanced Accelerator Applications (AAAP) Rises: Stock Up 6.2%
by Zacks Equity Research
Advanced Accelerator Applications S.A. (AAAP) shares rose a little above 6% in the last trading session.
Galmed Pharmaceuticals (GLMD) Catches Eye: Stock Gains 15.7%
by Zacks Equity Research
Galmed Pharmaceuticals Ltd. (GLMD) shares jumped nearly 16% in the last trading session.
Today's Strong Buys Breaking Out to New Highs
by David Bartosiak
Another video diary of today's price action to go along with strong buys breaking out to new highs
Calithera Biosciences (CALA) Rises: Stock Moves Up 19.3%
by Zacks Equity Research
Calithera Biosciences, Inc. (CALA) shares rose over 19% in the last trading session.
Acadia Healthcare (ACHC) Tops Q4 Earnings, Gives 2017 View
by Zacks Equity Research
Acadia Healthcare Company Inc. (ACHC) reported fourth-quarter 2016 adjusted earnings of 59 cents per share, which surpassed the Zacks Consensus Estimate by 4 cents.
Advanced Accelerator (AAAP) Catches Eye: Stock Jumps 5.4%
by Zacks Equity Research
Advanced Accelerator Applications S.A. (AAAP) moved big last session, as its shares rose over 5% on the day.